Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Clinical trial NCT05675787 · UNKNOWN

Trial details

NCT number: NCT05675787
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Atypical Endometrial Hyperplasia Endometrial Carcinoma Stage I

Start date: 2023-01-06
Primary completion: 2025-08-31
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.